AMOXICILLIN SUGAR FREE

4) • The severity and the site of the infection • The age, weight and renal function of the patient; as shown below The duration of therapy should be determined by the type of infection and the response of the patient, and should generally be as short as possible.

4 regarding prolonged therapy). g. g. 4) Early stage: 500 mg to 1 g every 8 hours up to a maximum of 4 g/day in divided doses for 14 days (10 to 21 days) Late stage (systemic involvement): 500 mg to 2 g every 8 hours up to a maximum of 6 g/day in divided doses for 10 to 30 days* Consideration should be given to the official treatment guidelines for each indication Children <40 kg Children may be treated with Amoxicillin capsules, dispersible tablets, suspensions or sachets.

Amoxicillin Paediatric Suspension is recommended for children under six months of age. Children weighing 40 kg or more should be prescribed the adult dosage. 4) Early stage: 25 to 50 mg/kg/day in three divided doses for 10 to 21 days Late stage (systemic involvement): 100 mg/kg/day in three divided doses for 10 to 30 days + Consideration should be given to the official treatment guidelines for each indication.

*Twice daily dosing regimens should only be considered when the dose is in the upper range. Elderly No dose adjustment is considered necessary Renal impairment GFR (ml/min) Adults and children ≥ 40 kg Children < 40 kg# greater than 30 no adjustment necessary no adjustment necessary 10 to 30 maximum 500 mg twice daily 15 mg/kg given twice daily (maximum 500 mg twice daily) less than 10 maximum 500 mg/day.

15 mg/kg given as a single daily dose (maximum 500 mg)# In the majority of cases, parenteral therapy is preferred. In patients receiving haemodialysis Amoxicillin may be removed from the circulation by haemodialysis Haemodialysis Adults and children Over 40 kg 500 mg every 24 h Prior to haemodialysis one additional dose of 500mg should be administered.

In order to restore circulating drug levels, another dose of 500mg should be administered after haemodialysis. Children under 40 kg 15 mg/kg/day given as a single daily dose (maximum 500 mg). Prior to haemodialysis one additional dose of 15 mg/kg should be administered.

In order to restore circulating drug levels, another dose of 15 mg/kg should be administered after haemodialysis. In patients receiving peritoneal dialysis Amoxicillin maximum 500 mg/day. 8). Method of administration Amoxicillin is for oral use.

The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and skin rash. The ADRs derived from clinical studies and post-marketing surveillance with amoxicillin, presented by MedDRA System Organ Class are listed below.

The following terminologies have been used in order to classify the occurrence of undesirable effects Very common (≥1/10) Common (≥1/100 to <1/10) Uncommon (≥1/1000 to <1/100) Rare (≥1/10,000 to <1/1000), Very rare (<1/10,000) Not known (cannot be estimated from the available data).

Infections and infestations Very Rare:

Mucocutaneous Candidiasis Blood and lymphatic system disorders Very rare: Reversible leucopenia (including severe neutropenia or agranulocytosis), reversible thrombocytopenia and haemolytic anaemia. 4), serum sickness and hypersensitivity vasculitis.

4). 4). 4) Gastrointestinal disorders Clinical Trial Data *Common: Diarrhoea and nausea. *Uncommon: Vomiting. 4). 4) Hepato-biliary disorders Very rare: Hepatitis and cholestatic jaundice. A moderate rise in AST and/or ALT. 4). 4) Renal and urinary tract disorders Very rare: Interstitial nephritis.

9) *The incidence of these AE's was derived from clinical studies involving a total of approximately 6,000 adult and paediatric patients taking amoxicillin. # Superficial tooth discolouration has been reported in children. Good oral hygiene may help to prevent tooth discolouration as it can usually be removed by brushing.

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.

8). Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients on penicillin therapy. 8). These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals.

If an allergic reaction occurs, amoxicillin therapy must be discontinued and appropriate alternative therapy instituted. 8). DIES is an allergic reaction with the leading symptom of protracted vomiting (1-4 hours after drug administration) in the absence of allergic skin or respiratory symptoms.

Further symptoms could comprise abdominal pain, diarrhoea, hypotension or leucocytosis with neutrophilia. There have been severe cases including progression to shock. g. 8). 1). This particularly applies when considering the treatment of patients with urinary tract infections and severe infections of the ear, nose and throat.

Crystalluria In patients with reduced urine output, crystalluria (including acute renal injury) has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria.

9). 2). 8). This reaction requires amoxicillin discontinuation and contra-indicates any subsequent administration. Amoxicillin should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.

Overgrowth of non-susceptible microorganisms Prolonged use may occasionally result in overgrowth of non-susceptible organisms. 8). Therefore, it is important to consider this diagnosis in patients who present with diarrhoea during or subsequent to the administration of any antibiotics.

1. g. g. a cephalosporin, carbapenem or monobactam).